Nakamuraya Co., Ltd. operates in the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nakamuraya Co., Ltd. with three other
bakery and confectionary companies in Asia:
GlaxoSmithKline Consumer Healthcare Limited
sales of 39.86 billion Indian Rupees [US$621.89 million]
of which 100%
Imuraya Group Company Limited
(42.00 billion Japanese Yen [US$384.70 million]
of which 88%
was Distribution Business), and
Morinaga & Co Ltd
(199.48 billion Japanese Yen [US$1.83 billion]
of which 95%
was Food Products).
Nakamuraya Co., Ltd. reported sales of ¥41.90 billion (US$383.81 million)
March of 2017.
a very small
increase of 1.3%
versus 2016, when the company's sales were ¥41.37 billion.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Nakamuraya Co., Ltd. had sales
of ¥41.02 billion.
Sales of Other Businesses saw an increase
that was more than double the company's growth rate: sales were up
5.7% in 2017, from
¥881.81 million to ¥932.03 million.
Nakamuraya Co., Ltd. also saw significant increases in sales in
Confectionery Business (up 1.9% to ¥29.67 billion)
Food Business (up 3.8% to ¥7.21 billion)
Not all segments of Nakamuraya Co., Ltd. experienced an increase in sales in 2017:
sales of Real Estate Leasing Business fell 10.5% to ¥1.16 billion.
(However, this segment's sales were only a very small portion of the company's overall sales).
Nakamuraya Co., Ltd. also experienced decreases in sales in
Restaurant Business (down 6.0% to ¥2.93 billion)